Hims and Hers Health Inc vs Somnigroup International Inc. Common Stock — how do they compare? Hims and Hers Health Inc trades at $27.66 (market cap $6.93B), while Somnigroup International Inc. Common Stock trades at $62 (market cap $14.48B). The key difference: Somnigroup International Inc. Common Stock is far larger — about 2.1× Hims and Hers Health Inc's market cap, and Somnigroup International Inc. Common Stock pays a 1.08% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Somnigroup International Inc. Common Stock for 0 Days on average.
| HIMS | SGI | |
|---|---|---|
Market Cap | $6.93B | $14.48B |
Volume | 9,771,956 | 1,734,399 |
Sector | Health | Consumer Cyclical |
52-Week High | $62.76 | $97.99 |
52-Week Low | $14.52 | $61.49 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $7.64B | $20.78B |
Dividend Yield | — | 1.08% |
Signals from Pluang's Aura AI — not financial advice
HIMS trades at $29.71, down 3.04% today, amid ongoing securities class action lawsuits. The stock shows bullish technical signals with strong moving average support and key resistance at $32. Fundamentally, while revenue grew to $2.35B in 2025, the company posted a net loss of -$142M in 2026 with negative profit margins, though it maintains a solid gross margin of 68.4%.
The investment outlook is mixed: technical indicators suggest near-term upside potential toward the $32.17 consensus target, but fundamental weakness and legal overhangs pose significant risks. Analyst sentiment leans cautious with 65% hold ratings, reflecting concerns about profitability and regulatory challenges despite growth prospects.
Somnigroup International (SGI) trades at $62.87, up 0.75% with neutral technical signals. The company shows strong profitability with 44.24% gross margins and has beaten earnings estimates for three consecutive quarters. Recent acquisition of Leggett & Platt enhances vertical integration with $75M synergy target. Analyst consensus is strongly bullish with 91% buy ratings and $94.50 price target, representing 50% upside potential from current levels.
SGI presents compelling growth prospects through strategic acquisitions and operational efficiencies, though faces margin pressures in weak bedding markets. The stock trades at reasonable valuations (P/E 24.85) with improving cash flow trends expected in 2026. Key risks include integration execution and market competition, but strong institutional interest and insider buying support the bullish case.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →Somnigroup International Inc. (formerly Tempur Sealy International) is a bedding and sleep-products company that designs, manufactures, distributes, and retails mattresses and related products. It operates through Tempur Sealy North America, Tempur Sealy International, and Mattress Firm, with brands including Tempur-Pedic, Sealy, Stearns & Foster, and Mattress Firm.
Read more on SGI →